55
total announcements
MAXHEALTH.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 15 Oct 2026
Market Cap
₹82,975 Cr
P/E (TTM)
57.2
P/E (Forward)
36.6
EPS (TTM)
₹14.91
52W Low
₹842.05
52W High
₹1,221.90
Dividend Yield
0.23%
Beta
0.10
Price / Book
7.7
Debt / Equity
32.4
Revenue (TTM)
₹8,712 Cr
Gross Margin
62.52%
Operating Margin
19.73%
Max Healthcare Institute Limited
Max Healthcare Institute Limited has informed the Exchange that CARE Ratings Limited has upgraded the credit rating for Crosslay Remedies Limited, a wholly-owned material subsidiary of the Company, with a stable outlook.
Max Healthcare Institute Limited
Max Healthcare Institute Limited has informed the Exchange about Credit Rating reaffirmation by CARE Ratings Limited.
Max Healthcare Institute Limited
Max Healthcare Institute Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming that they have not received any request for dematerialization of shares during the quarter ended September 30, 2026.
Max Healthcare Institute Limited
Max Healthcare Institute Limited has informed the Exchange about the pendency of litigation against its subsidiary, Kalinga Hospital Ltd., and the adjournment of the matter to October 29, 2026, for further hearing.
Max Healthcare Institute Limited
Max Healthcare Institute Limited has closed its trading window for insiders from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026, in compliance with SEBI regulations.
Max Healthcare Institute Limited
Max Healthcare Institute Limited has informed the Exchange about a postal ballot notice for approval of special resolutions related to grant of performance-linked restricted stock units to employees, alteration of main objects clause of the Memorandum of Association, and other matters.
Max Healthcare Institute Limited
Max Healthcare Institute Limited has informed the Exchange regarding Postal Ballot Notice for approval of special resolutions, including grant of Performance Linked Restricted Stock Units to eligible employees and alteration of Main Objects Clause of the Memorandum of Association.
Max Healthcare Institute Limited
Max Healthcare Institute Limited has disclosed under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that it has received an ESG rating from Niche Ninety Nine Capability and Certifications (OPC) Private Limited, a SEBI registered ESG Rating Provider, which has assigned a 'Leader' rating category of 72.
Max Healthcare Institute Limited
Max Healthcare Institute Limited has informed the Exchange about its schedule of investor conference on September 21, 2026, at St. Regis, Mumbai, where representatives of the company will participate in one-on-one and group meetings.
Max Healthcare Institute Limited
Max Healthcare Institute Limited has informed the Exchange about its participation in an investor conference on September 16, 2026, at The Oberoi, Gurgaon. The conference is a one-on-one and physical forum, and the company's participation was finalized today, hence the short notice.
Max Healthcare Institute Limited
Max Healthcare Institute Limited has informed the Exchange about disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding pendency of litigation against its subsidiary Kalinga Hospital Ltd.
Max Healthcare Institute Limited
Max Healthcare Institute Limited has informed the Exchange about newspaper publication in Form INC-26 regarding shifting of Registered office from the 'State of Maharashtra' to the 'State of Haryana'.
Max Healthcare Institute Limited
Max Healthcare Institute Limited has informed the Exchange about the update on infusion of funds in Kalinga Hospital Ltd. The company has received a communication from KHL confirming the allotment of 50,21,212 equity shares to the Company on a rights basis, increasing its shareholding in KHL from ~58.28% to ~66.15%.
Max Healthcare Institute Limited
Max Healthcare Institute Limited has informed the Exchange regarding the allotment of 33,765 equity shares under the Employee Stock Option Scheme 2022 to eligible employees.
Max Healthcare Institute Limited
Max Healthcare Institute Limited has informed the Exchange about infusion of funds in Kalinga Hospital Ltd. by subscribing to equity shares on rights basis.
Max Healthcare Institute Limited
Max Healthcare Institute Limited has inaugurated a new 400 beds tower at its Max Smart Super Speciality Hospital, Saket, in Delhi, increasing its total capacity to approximately 1,200 beds.
Max Healthcare Institute Limited
Max Healthcare Institute Limited has informed the Exchange about disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding a show cause cum demand notice received by its wholly-owned subsidiary Alps Hospital Limited from the Office of the Pr. Additional Director General, Mumbai Zonal Unit, Directorate General of Goods & Services Tax Intelligence for alleged non-payment of GST on variable management fee.
Max Healthcare Institute Limited
Max Healthcare Institute Limited has announced its Q1 FY27 earnings, with revenue and operating EBITDA growth of 16% and 15% year-on-year, respectively. The company has also made progress on its capacity expansion plans, including the operationalization of 50% of the 400-bed brownfield tower at Max Smart and the integration of Max Bhubaneswar into the network.
Max Healthcare Institute Limited
Max Healthcare Institute Limited has informed the Exchange about a development in a pending litigation against its subsidiary Kalinga Hospital Ltd. The matter was heard by the National Company Law Tribunal on August 19, 2026, and was adjourned for further hearing on September 8, 2026.
Max Healthcare Institute Limited
Max Healthcare Institute Limited has informed the Exchange about Investor Presentation for Motilal Oswal 22nd Annual Global Investor Conference on August 18, 2026.